Prominence of an O75 clonal group (clonal complex 14) among non-st131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 7, 2012, Pages 3898-3904

  Platell, Joanne L ^a   Trott, Darren J ^a,b   Johnson, James R ^c   Heisig, Peter ^d   Heisig, Anke ^d   Clabots, Connie R ^c   Johnston, Brian ^c   Cobbold, Rowland N ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFALOTIN; CEFOXITIN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ENROFLOXACIN; GENTAMICIN; MOXIFLOXACIN; PIPERACILLIN; PRADOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CLONAL SPECIES; DOG; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O75; EXTRAINTESTINAL ESCHERICHIA COLI INFECTION; GENE SEQUENCE; GENOTYPE; HUMAN; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; QUANTITATIVE ANALYSIS;

ALLELES; ANIMALS; ANTI-BACTERIAL AGENTS; DOGS; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; FLUOROQUINOLONES; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; VIRULENCE;

EID: 84862565760     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.06120-11     Document Type: Article

References (40)

1. Blanco J, et al. 2011. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b: H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. J. Antimicrob. Chemother. 66:2011-2021.
2. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
3. Clermont O, et al. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274-277.
4. Clermont O, Johnson JR, Menard M, Denamur E. 2007. Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. Diagn. Microbiol. Infect. Dis. 57:129-136. (Pubitemid 46135872)
5. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing: twentieth informational supplement M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals 3rd ed: approved standard M31-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Devine DA, Robinson L, Roberts AP. 1989. Occurrence of K1, K5 and O antigens in Escherichia coli isolates from patients with urinary tract infections or bacteraemia. J. Med. Microbiol. 30:295-299. (Pubitemid 20023714)
8. Ewers C, et al. 2010. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals. J. Antimicrob. Chemother. 65:651-660.
9. Gibson JS, et al. 2010. Identification of qnr and aac(6′)-1b-cr plasmid-mediated fluoroquinolone resistance determinants in multidrug-resistant Enterobacter spp. isolated from extraintestinal infections in companion animals. Vet. Microbiol. 143:329-336.
10. Johnson JR, Delavari P, Kuskowski M, Stell AL. 2001. Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. J. Infect. Dis. 183:78-88. (Pubitemid 32043044)
11. Johnson JR, Gajewski A, Lesse AJ, Russo TA. 2003. Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections. J. Clin. Microbiol. 41:5798-5802. (Pubitemid 37543292)
12. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51:286-294.
13. Johnson JR, et al. 2008. Virulence genotypes and phylogenetic background of Escherichia coli serogroup O6 isolates from humans, dogs, and cats. J. Clin. Microbiol. 46:417-422. (Pubitemid 351231280)
14. Johnson JR, Kuskowski MA, Gajewski A, Sahm DF, Karlowsky JA. 2004. Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001. J. Infect. Dis. 190:1739-1744. (Pubitemid 39487816)
15. Johnson JR, et al. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 53:2733-2739.
16. Johnson JR, Miller S, Johnston B, Clabots C, Debroy C. 2009. Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and urovirulent E. coli strains among dogs and cats within a household. J. Clin. Microbiol. 47:3721-3725.
17. Johnson JR, et al. 2005. Distribution and characteristics of Escherichia coli clonal group A. Emerg. Infect. Dis. 11:141-145. (Pubitemid 40093371)
18. Johnson JR, et al. 2000. Evidence of commonality between canine and human extraintestinal pathogenic Escherichia coli strains that express papG allele III. Infect. Immun. 68:3327-3336. (Pubitemid 30340427)
19. Johnson JR, Stell AL. 2000. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181:261-272. (Pubitemid 30049057)
20. Johnson JR, et al. 2002. Global molecular epidemiology of the O15: K52:H1 extraintestinal pathogenic Escherichia coli clonal group: evidence of distribution beyond Europe. J. Clin. Microbiol. 40:1913-1923. (Pubitemid 34596363)
21. Johnson JR, et al. 2000. Analysis of the F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay. Infect. Immun. 68:1587-1599. (Pubitemid 30108562)
22. Kurazono H, et al. 2003. Distribution of the usp gene in uropathogenic Escherichia coli isolated from companion animals and correlation with serotypes and size-variations of the pathogenicity island. Microbiol. Immunol. 47:797-802. (Pubitemid 37288256)
23. Maslow JN, Mulligan ME, Arbeit RD. 1994. Recurrent Escherichia coli bacteremia. J. Clin. Microbiol. 32:710-714. (Pubitemid 24062948)
24. Maynard C, et al. 2004. Heterogeneity among virulence and antimicrobial resistance gene profiles of extraintestinal Escherichia coli isolates of animal and human origin. J. Clin. Microbiol. 42:5444-5452. (Pubitemid 39664318)
25. Nicolas-Chanoine MH, et al. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281.
26. Nimmich W, Voigt W, Seltmann G. 1997. Characterization of urinary Escherichia coli O75 strains. J. Clin. Microbiol. 35:1112-1117. (Pubitemid 27175235)
27. Nowicki B, Barrish JP, Korhonen T, Hull RA, Hull SI. 1987. Molecular cloning of the Escherichia coli O75X adhesin. Infect. Immun. 55:3168-3173. (Pubitemid 18008294)
28. Obata-Yasuoka M, Ba-Thein W, Tsukamoto T, Yoshikawa H, Hayashi H. 2002. Vaginal Escherichia coli share common virulence factor profiles, serotypes and phylogeny with other extraintestinal E. coli. Microbiology 148:2745-2752.
29. Peddie BA, Little PJ. 1978. Serogroups of Escherichia coli in symptomatic and asymptomatic urinary tract infections in Christchurch. Zentralbl. Bakteriol. Orig. A 240:320-325. (Pubitemid 8340139)
30. Pitout JD, Gregson DB, Campbell L, Laupland KB. 2009. Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob. Agents Chemother. 53:2846-2851.
31. Platell JL, et al. 2011. Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia. Antimicrob. Agents Chemother. 55:3782-3787.
32. Platell JL, Cobbold RN, Johnson JR, Trott DJ. 2010. Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia. J. Antimicrob. Chemother. 65:1936-1938.
33. Pomba C, da Fonseca JD, Baptista BC, Correia JD, Martinez-Martinez L. 2009. Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6′)-Ib-cr genes in a dog. Antimicrob. Agents Chemother. 53:327-328.
34. Ribot EM, et al. 2006. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog. Dis. 3:59-67.
35. Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66:1-14.
36. Sidjabat HE, et al. 2009. Colonisation dynamics and virulence of two clonal groups of multidrug-resistant Escherichia coli isolated from dogs. Microbes Infect. 11:100-107.
37. Sidjabat HE, Derrington P, Nimmo GR, Paterson DL. 2010. Escherichia coli ST131 producing CTX-M-15 in Australia. J. Antimicrob. Chemother. 65:1301-1303.
38. Simpson EH. 1949. Measurement of diversity. Nature 163:688.
39. Tenover F, et al. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
40. Wetzstein HG. 2005. Comparative mutant prevention concentrations of pradofloxacin and other veterinary fluoroquinolones indicate differing potentials in preventing selection of resistance. Antimicrob. Agents Chemother. 49:4166-4173.